Inflammation and repair in viral hepatitis C. (Q36997773)

17 August 2017

1 reference

title

Inflammation and repair in viral hepatitis C. (English)

1 reference

17 August 2017

1 reference

20

Giuliano Ramadori

1 reference

17 August 2017

12

Geoffrey W McCaughan

1 reference

17 August 2017

10

Mark D Gorrell

1 reference

17 August 2017

6

Nir Hilzenrat

1 reference

17 August 2017

1

Manuela G Neuman

1 reference

17 August 2017

Kevin Sha

2

1 reference

17 August 2017

Rustan Esguerra

3

1 reference

17 August 2017

Sam Zakhari

4

1 reference

17 August 2017

Robert E Winkler

5

1 reference

17 August 2017

Jonathan Wyse

7

1 reference

17 August 2017

Curtis L Cooper

8

1 reference

17 August 2017

Devanshi Seth

9

1 reference

17 August 2017

Paul S Haber

11

1 reference

17 August 2017

Maria A Leo

13

1 reference

17 August 2017

Charles S Lieber

14

1 reference

17 August 2017

Mihai Voiculescu

15

1 reference

17 August 2017

Eugenia Buzatu

16

1 reference

17 August 2017

Camelia Ionescu

17

1 reference

17 August 2017

Jozsef Dudas

18

1 reference

17 August 2017

Bernhard Saile

19

1 reference

17 August 2017

1 June 2008

1 reference

Digestive Diseases and Sciences

17 August 2017

1 reference

17 August 2017

53

1 reference

17 August 2017

1468-1487

1 reference

17 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-007-0047-3

17 August 2017

0 references

cites work

Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Hepatitis C and alcohol: fundamental and translational research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0047-3

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

21 January 2018

1 reference

12 December 2020

Intrahepatic gene expression in human alcoholic hepatitis.

1 reference

12 December 2020

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

1 reference

12 December 2020

Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses

1 reference

12 December 2020

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

1 reference

12 December 2020

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy

1 reference

12 December 2020

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

1 reference

12 December 2020

Portal tract fibrogenesis in the liver

1 reference

12 December 2020

Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection

1 reference

12 December 2020

Modelling how ribavirin improves interferon response rates in hepatitis C virus infection

1 reference

12 December 2020

Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy.

1 reference

12 December 2020

Early up-regulation of chemokine expression in fulminant hepatic failure

1 reference

12 December 2020

Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection

1 reference

12 December 2020

Protection against persistence of hepatitis C.

1 reference

12 December 2020

Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome

1 reference

12 December 2020

Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

1 reference

12 December 2020

Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis.

1 reference

12 December 2020

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

12 December 2020

Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation

1 reference

12 December 2020

DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy

1 reference

12 December 2020

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

1 reference

12 December 2020

Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection

1 reference

12 December 2020

Impact of protease inhibitors on intrahepatic hepatitis C virus viral load

1 reference

12 December 2020

Ontogenesis of the murine hepatic extracellular matrix: an immunohistochemical study

1 reference

12 December 2020

Increased hepatitis C virus (HCV)-specific CD4+CD25 + regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels

1 reference

12 December 2020

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

1 reference

12 December 2020

Analysis of a successful immune response against hepatitis C virus

1 reference

12 December 2020

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

1 reference

12 December 2020

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

12 December 2020

Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.

1 reference

12 December 2020

Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy

1 reference

12 December 2020

Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection

1 reference

12 December 2020

Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV.

1 reference

12 December 2020

Single-dose pharmacokinetics and tolerability of pegylated interferon-alpha2b in young and elderly healthy subjects

1 reference

12 December 2020

Virus interference. I. The interferon

1 reference

12 December 2020

To kill or to cure: options in host defense against viral infection.

1 reference

12 December 2020

Emerging strategies for pegylated interferon combination therapy

1 reference

12 December 2020

1 reference

12 December 2020

Critical role of CXC chemokines in endotoxemic liver injury in mice

1 reference

12 December 2020

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

1 reference

12 December 2020

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

1 reference

12 December 2020

Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection

1 reference

12 December 2020

Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?

1 reference

12 December 2020

Cell adhesion and migration. IV. Lymphocyte trafficking in the intestine and liver.

1 reference

12 December 2020

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease

1 reference

12 December 2020

Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.

1 reference

12 December 2020

Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein

1 reference

12 December 2020

Consensus interferon induces peak mRNA accumulation at lower concentrations than interferon-alpha 2a

1 reference

12 December 2020

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

12 December 2020

Alcohol modulation of human normal T-cell activation, maturation, and migration

1 reference

12 December 2020

Dissecting racial and ethnic differences

1 reference

12 December 2020

Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats

1 reference

12 December 2020

A target on the move: innate and adaptive immune escape strategies of hepatitis C virus

1 reference

12 December 2020

Decrease of platelet-endothelial cell adhesion molecule 1-gene-expression in inflammatory cells and in endothelial cells in the rat liver following CCl(4)-administration and in vitro after treatment with TNFalpha

1 reference

12 December 2020

Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease

1 reference

12 December 2020

Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells

1 reference

12 December 2020

Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGFbeta1 and TGF-beta3

1 reference

12 December 2020

[Fibrogenesis and liver transplantation]

1 reference

12 December 2020

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

1 reference

12 December 2020

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

1 reference

12 December 2020

Liver transplantation in adults coinfected with HIV.

1 reference

12 December 2020

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

1 reference

12 December 2020

CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy

1 reference

12 December 2020

Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy

1 reference

12 December 2020

Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humans

1 reference

12 December 2020

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

1 reference

12 December 2020

Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease

1 reference

12 December 2020

Interferons and viruses: signaling for supremacy.

1 reference

12 December 2020

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection

1 reference

12 December 2020

Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation

1 reference

12 December 2020

Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.

1 reference

12 December 2020

Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate

1 reference

12 December 2020

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

12 December 2020

Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.

1 reference

12 December 2020

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

12 December 2020

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 reference

12 December 2020

Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection

1 reference

12 December 2020

Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis

1 reference

12 December 2020

Attenuated liver fibrosis in the absence of B cells

1 reference

12 December 2020

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

1 reference

12 December 2020

Interaction of alcohol and hepatitis C virus infection on severity of liver disease

1 reference

12 December 2020

The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host

1 reference

12 December 2020

Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses

1 reference

12 December 2020

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

12 December 2020

Mechanisms of HCV reinfection and allograft damage after liver transplantation

1 reference

12 December 2020

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study

1 reference

12 December 2020

Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy

1 reference

12 December 2020

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

1 reference

12 December 2020

Viral and host immune regulatory mechanisms in hepatitis C virus infection.

1 reference

12 December 2020

Noncytolytic control of viral infections by the innate and adaptive immune response

1 reference

12 December 2020

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

1 reference

12 December 2020

Interaction of alcohol and hepatitis viral proteins: implication in synergistic effect of alcohol drinking and viral hepatitis on liver injury

1 reference

12 December 2020

Mitochondrial toxic effects and ribavirin

1 reference

12 December 2020

Expression of activin A is increased in cirrhotic and fibrotic rat livers

1 reference

12 December 2020

HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype

1 reference

12 December 2020

TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy.

1 reference

12 December 2020

Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation

1 reference

12 December 2020

Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C

1 reference

12 December 2020

Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model

1 reference

12 December 2020

Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC)

1 reference

12 December 2020

Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.

1 reference

12 December 2020

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance

1 reference

12 December 2020

Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients

1 reference

12 December 2020

Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection

1 reference

12 December 2020

Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved

1 reference

12 December 2020

Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy

1 reference

12 December 2020

Influence of viral hepatitis on HIV infection

1 reference

12 December 2020

Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon

1 reference

12 December 2020

Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury

1 reference

12 December 2020

Human immunodeficiency virus (HIV) protease inhibitors have no effect on hepatitis C virus (HCV) serum levels of HIV-HCV co-infected patients

1 reference

12 December 2020

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

1 reference

12 December 2020

Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C.

1 reference

12 December 2020

Host genetic determinants in hepatitis C virus infection

1 reference

12 December 2020

Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor beta1

1 reference

12 December 2020

Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation

1 reference

12 December 2020

Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C.

1 reference

12 December 2020

Alanine aminotransferase decrease in HIV–hepatitis C virus co-infected patients responding to antiretroviral therapy

1 reference

12 December 2020

Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans.

1 reference

12 December 2020

Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation

1 reference

12 December 2020

Consensus interferon versus interferon-alpha 2b plus ribavirin in patients with relapsing HCV infection

1 reference

12 December 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 December 2020

Unravelling hepatitis C virus replication from genome to function

1 reference

12 December 2020

Predictors of patient and graft survival following liver transplantation for hepatitis C.

1 reference

12 December 2020

Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.

1 reference

12 December 2020

Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression

1 reference

12 December 2020

Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

1 reference

12 December 2020

Transcriptional control by the TGF-beta/Smad signaling system

1 reference

12 December 2020

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

1 reference

12 December 2020

Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis

1 reference

12 December 2020

Hepatic steatosis is a predictor of poor response to interferon alpha-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C.

1 reference

12 December 2020

Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.

1 reference

12 December 2020

HEPATIC MESENCHYMAL CELL REACTION IN LIVER DISEASE

1 reference

12 December 2020

Novel morphologic findings in alcoholic liver disease

1 reference

12 December 2020

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

1 reference

12 December 2020

Alcohol and hepatitis C

1 reference

12 December 2020

Lymphocyte and macrophage populations in the liver.

1 reference

12 December 2020

Mechanisms of alcoholic liver disease: cytokines

1 reference

12 December 2020

Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage

1 reference

12 December 2020

Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo

1 reference

12 December 2020

Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C

1 reference

12 December 2020

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

1 reference

12 December 2020

Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon

1 reference

12 December 2020

Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis

1 reference

12 December 2020

Specificity, diversity, and regulation in TGF-beta superfamily signaling.

1 reference

12 December 2020

Characterization of the IGF axis components in isolated rat hepatic stellate cells

1 reference

12 December 2020

Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival

1 reference

12 December 2020

Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine. Prometheus Study Group

1 reference

12 December 2020

Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation

1 reference

12 December 2020

Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins

1 reference

12 December 2020

Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase

1 reference

12 December 2020

Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects

1 reference

12 December 2020

B cells: no longer bystanders in liver fibrosis

1 reference

12 December 2020

Interferon: the pathways of discovery I. Molecular and cellular aspects

1 reference

12 December 2020

Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question

1 reference

12 December 2020

Fibrosis progression in chronic hepatitis C virus infection

1 reference

12 December 2020

Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: the null responder

1 reference

12 December 2020

Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

1 reference

12 December 2020

Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life

1 reference

12 December 2020

Activin: an important regulator of wound repair, fibrosis, and neuroprotection

1 reference

12 December 2020

Pegylated interferon plus ribavirin in chronic hepatitis C. More than half of patients show a lasting response

1 reference

12 December 2020

Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C.

1 reference

12 December 2020

RNA virus error catastrophe: direct molecular test by using ribavirin

1 reference

12 December 2020

Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection

1 reference

12 December 2020

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

12 December 2020

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

1 reference

12 December 2020

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

1 reference

12 December 2020

Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C.

1 reference

12 December 2020

Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1

1 reference

12 December 2020

Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy

1 reference

12 December 2020

Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection

1 reference

12 December 2020

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells

1 reference

12 December 2020

Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit.

1 reference

12 December 2020

10.1007/S10620-007-0047-3

Identifiers

DOI

1 reference

release_vyyk3hrwovcvdlrepf27cmbv74

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vyyk3hrwovcvdlrepf27cmbv74

24 November 2022

mapped directly with Wikidata item

1 reference